Montai Health
Michael Joseph Sizensky has a diverse work experience in the pharmaceutical industry. Currently, they are employed as a Principal Scientist at Montai Health, a position they started in March 2023. Prior to this, they worked at Sunovion Pharmaceuticals for a significant portion of their career. At Sunovion Pharmaceuticals, Michael held several roles, starting as an Associate Scientist in January 1997 and progressing through various positions, including Senior Associate Scientist, Principal Associate Scientist, Supervisor, Senior Pharmaceutical Scientist, and ultimately Principal Scientist. Their tenure at Sunovion Pharmaceuticals spanned from January 1997 to January 2023, and they made contributions at different levels within the research and development division of the company.
From 1985 to 1990, Michael Joseph Sizensky attended Rhode Island College, where they pursued a Bachelor of Science degree in Biology, with a focus on General Biology.
This person is not in any offices
Montai Health
Montai is harnessing nature's power through digital technology to treat and prevent chronic disease, hence improving health outcomes for as many people as possible. To address this crucial global concern, the business is pioneering cutting-edge technology to develop AnthromoleculeTM medications, which are derived from a privileged class ofcompounds with a history of safe human use. Our human-centered foundation can enable the rapid and repeatable development of safe, efficacious, and accessible medicines for as many diseases and people as possible by creating the world's first Anthromolecule Bioactivity Atlas, which comprehensively maps potent connections to all known biological pathways underlying disease.